艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

已收盘 07-21 16:00:00 EDT

256.10

+2.72

+1.07%

盘后256.11

+0.01+0.00%

19:59 EDT

最高257.06	最低252.60	成交量481.93万
今开253.70	昨收253.38	日振幅1.76%
总市值4,526亿	流通市值4,515亿	总股本17.67亿
成交额12.32亿	换手率0.27%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":256.1,"timestamp":1784664000000,"preClose":253.38,"halted":0,"volume":4819290,"hourTrading":{"tag":"盘后","latestPrice":256.11,"preClose":256.1,"latestTime":"19:59 EDT","volume":1706044,"amount":436900655.6461,"timestamp":1784678371262,"change":0.01,"changeRate":0.000039,"amplitude":0.001132},"delay":0,"changeRate":0.010734864630199807,"floatShares":1762950764,"shares":1767384632,"eps":2.030053,"marketStatus":"已收盘","change":2.72,"latestTime":"07-21 16:00:00 EDT","open":253.7,"high":257.06,"low":252.6001,"amount":1231990861.8318,"amplitude":0.017602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.030053,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784707200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":253.38,"dividendRate":0.026318,"preHourTrading":{"tag":"盘前","latestPrice":253.4,"preClose":253.38,"latestTime":"09:29 EDT","volume":216011,"amount":54730845.317040004,"timestamp":1784640599999,"change":0.02,"changeRate":0.000079,"amplitude":0.013434},"postHourTrading":{"tag":"盘后","latestPrice":256.11,"preClose":256.1,"latestTime":"19:59 EDT","volume":1706044,"amount":436900655.6461,"timestamp":1784678371262,"change":0.01,"changeRate":0.000039,"amplitude":0.001132},"volumeRatio":0.819686,"impliedVol":0.3171,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"1186168369","title":"异动解读｜艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1186168369","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186168369?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:26","pubTimestamp":1784212008,"startTime":"0","endTime":"0","summary":"7月16日，艾伯维公司盘中上涨3.01%，报251.72美元/股，成交额2.3亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价。花旗集团7月15日将目标价从230美元上调至260美元；瑞银同期上调至260美元；美国银行将目标价大幅上调至276美元，并将艾伯维列为生物制药板块首选标的；加拿大皇家银行维持\"跑赢大市\"评级，目标价上调至280美元。FactSet统计显示，艾伯维当前平均评级为\"增持\"，平均目标价266.60美元。公司将于7月31日公布第二季度财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184491056","title":"Skinmedica® 持续投资研发，深化在再生科学领域的承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1184491056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184491056?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:06","pubTimestamp":1784030794,"startTime":"0","endTime":"0","summary":"Skinmedica®正通过持续投入研发，进一步巩固其在再生科学领域的坚定承诺。这一举措彰显了该品牌致力于推动皮肤健康与再生领域前沿科技发展的长期战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","IE00BDGV0183.EUR","LU0823416689.USD","LU0320765646.SGD","RXL","IE00BLSP4239.USD","LU0310800379.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE000F7OJYX1.SGD","LU1244550221.USD","LU0689472784.USD","LU0859254822.USD","IE00B4R5TH58.HKD","LU2087621335.USD","LU2357627491.SGD","SG9999001440.SGD","LU0029864427.USD","XLV","LU0122379950.USD","IE000MB6IJN5.SGD","LU0661504455.SGD","LU1057294990.SGD","FTXH","LU0256863811.USD","LU0234572021.USD","LU1934455277.USD","LU1244550494.USD","LU1732799900.SGD","LU1496350171.SGD","LU2237443465.HKD","FHLC","LU0211328371.USD","LU0114720955.EUR","LU2237443622.USD","LU1989772840.SGD","LU0310799852.SGD","IE000SO60NU8.SGD","LU1291159041.SGD","LU0289961442.SGD","LU0882574055.USD","LU1037948541.HKD","LU1839511570.USD","LU0203347892.USD","LU0069063385.USD","LU1670628061.USD","LU1983299246.USD","LU2023251221.USD","LU0170899867.USD","LU1732800096.USD","IE000BZT7R73.USD","LU0211327993.USD","LU0965509283.SGD","LU0868494708.USD","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU0689626769.HKD","IE000WAW04H5.SGD","LU1430594728.SGD","LU1670627923.USD","LU0820561909.HKD","LU0511384066.AUD","LU0472753341.HKD","SG9999015978.USD","LU0965508806.USD","LU0545039389.USD","LU0912757837.SGD","IE00B2B36J28.USD","LU1551013342.USD","BK4588","LU2347655156.SGD","SG9999015945.SGD","IYH","LU0098860793.USD","IE00BLSP4452.SGD","LU0289739343.SGD","LU1989771016.USD","LU1718418525.SGD","LU1061106388.HKD","IE00BGHQF631.EUR","LU0965509010.AUD","BK4139","IE00B19Z3B42.SGD","LU2468319806.SGD","SG9999015986.USD","ABBV","LU1244550577.SGD","LU2237443382.USD","LU0417517546.SGD","LU2237443978.SGD","AGNG","LU1267930573.SGD","SG9999011175.SGD","BK4585","IE0004445239.USD","LU1093756325.SGD","LU2237443549.SGD","LU0795875169.SGD","BK4566","IE00BVYPNW00.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","LU0942090050.USD","IE00BBT3K403.USD","LU0965509101.SGD","LU1934455194.USD","LU0158827948.USD","LU2089984988.USD","JDOC","SG9999015952.SGD","LU0795875086.SGD","LU2133065610.SGD","LU1003077747.HKD","LU1551013425.SGD","LU0949170772.SGD","LU2089283258.USD","IE0002141913.USD","LU1037948897.HKD","VHT","IE00BJT1NW94.SGD","LU1093756168.USD","IE00B42XCP33.USD","LU0820561818.USD","LU1267930490.SGD","PPH","LU0203345920.USD","LU1023059063.AUD","LU0057025933.USD","LU0738911758.USD","LU0198837287.USD","PJP","IE00B19Z3581.USD","BK4581","LU0256863902.USD","LU2089284900.SGD","BK4533","LU2129689431.USD","LU2129689514.USD","LU0456855351.SGD","LU0124676726.USD","LU1162221912.USD","BK4559","LU2129689605.HKD","LU0868494617.USD","IXJ","LU0861579265.USD","LU1989772923.USD","IE0002270589.USD","LU0943347566.SGD","LU1929549753.HKD","SG9999003800.SGD","BK4534","IE00BN8TJ469.HKD","LU1074936037.SGD","LU2112291526.USD","MEDX","IE0000B7K699.USD","LU0985320562.USD","LU0708994859.HKD","LU0128525929.USD","IE00B3PB1722.GBP","BK4550","LU0432979614.USD","LU1934455863.HKD","LU0234570918.USD","LU2237443895.HKD","LU1585245621.USD","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166898621","title":"艾伯维公司2026年第二季度计入2.91亿美元购买IPR&D费用，影响GAAP及调整后稀释每股收益0.17美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1166898621","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166898621?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:13","pubTimestamp":1783368797,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，艾伯维公司在2026年第二季度业绩中计入了高达2.91亿美元的“购买无形资产研发”费用。此项一次性支出对公司的财务指标产生了显著影响，具体表现为：按美国通用会计准则计算的稀释每股收益以及调整后的稀释每股收益均因此减少了0.17美元。购买IPR&D费用通常与收购交易相关，指为获取尚处研发阶段、尚未商业化的无形资产而支付的款项。投资者在评估公司核心运营业绩时，需关注此类调整项的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","IE000WAW04H5.SGD","LU0882574055.USD","LU2357627491.SGD","LU0965509010.AUD","RXL","IE000MB6IJN5.SGD","LU1037948541.HKD","SG9999015986.USD","PPH","IE0000B7K699.USD","SG9999015945.SGD","LU0661504455.SGD","LU1023059063.AUD","JDOC","LU1989772923.USD","LU0965508806.USD","LU2237443622.USD","LU0456855351.SGD","IE00BGHQF631.EUR","LU0289739699.SGD","LU1093756168.USD","XLV","VHT","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0545039389.USD","LU2237443978.SGD","LU2023251221.USD","LU1430594728.SGD","IE00B42XCP33.USD","LU0942090050.USD","LU2237443465.HKD","PJP","LU0211327993.USD","LU0203345920.USD","LU0310799852.SGD","IE0004445239.USD","LU0553294199.USD","LU0198837287.USD","LU0170899867.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU2133065610.SGD","LU2129689431.USD","LU1267930573.SGD","LU1267930490.SGD","LU0943347566.SGD","LU0823416689.USD","LU0320765646.SGD","LU0689626769.HKD","LU2347655156.SGD","LU0708994859.HKD","LU0795875169.SGD","LU1718418525.SGD","IE00BLSP4452.SGD","LU1670628061.USD","LU0211328371.USD","LU0256863811.USD","LU0965509283.SGD","LU0820561909.HKD","LU1093756325.SGD","IE000BZT7R73.USD","LU0795875086.SGD","IE00BN8TJ469.HKD","LU0310800379.SGD","IE00BDGV0183.EUR","FHLC","BK4533","LU0122379950.USD","LU0058720904.USD","LU2129689605.HKD","LU1244550494.USD","FTXH","LU1983299246.USD","LU1037948897.HKD","LU1929549753.HKD","IE000F7OJYX1.SGD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1732800096.USD","MEDX","LU0820561818.USD","BK4588","SG9999003800.SGD","BK4550","IE00BJJMRZ35.SGD","LU0859254822.USD","LU1989771016.USD","LU1551013425.SGD","LU1934455194.USD","LU2089283258.USD","LU0069063385.USD","LU2237443382.USD","BK4566","AGNG","IE00BBT3K403.USD","LU1003077747.HKD","LU0057025933.USD","LU1496350171.SGD","LU0965509101.SGD","LU0203347892.USD","LU1989772840.SGD","LU0124676726.USD","IE00BJT1NW94.SGD","LU1244550221.USD","LU2089984988.USD","LU0511384066.AUD","SG9999015978.USD","SG9999011175.SGD","LU0234572021.USD","LU0985320562.USD","LU0868494617.USD","LU2468319806.SGD","IE0002141913.USD","IE0009355771.USD","LU0738911758.USD","LU0472753341.HKD","LU0029864427.USD","LU0256863902.USD","LU1934455863.HKD","LU1496350502.SGD","LU2089284900.SGD","LU1162221912.USD","IE00BVYPNV92.GBP","LU1057294990.SGD","ABBV","IXJ","LU0234570918.USD","IYH","IE00BVYPNW00.USD","LU1670627923.USD","IE0002270589.USD","LU0128525929.USD","BK4585","LU0289961442.SGD","LU1934455277.USD","IE00B4R5TH58.HKD","IE00B3PB1722.GBP","IE00B2B36J28.USD","LU0912757837.SGD","LU1585245621.USD","LU0689472784.USD","LU2237443549.SGD","LU0868494708.USD","LU2129689514.USD","LU1244550577.SGD","BK4581","IE000SO60NU8.SGD","LU2112291526.USD","LU0098860793.USD","SG9999001440.SGD","BK4559","LU0432979614.USD","BK4534","LU1074936037.SGD","LU2237443895.HKD","LU1551013342.USD","LU0417517546.SGD","LU2087621335.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU1839511570.USD","LU0289739343.SGD","LU0949170772.SGD","LU0158827948.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135554237","title":"艾伯维宣布Tepkinly®（epcoritamab）联合来那度胺和利妥昔单抗获欧盟委员会批准用于治疗复发或难治性滤泡性淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1135554237","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135554237?lang=zh_cn&edition=full","pubTime":"2026-07-07 01:45","pubTimestamp":1783359934,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Tepkinly®（epcoritamab）与来那度胺及利妥昔单抗的联合治疗方案，已获得欧盟委员会批准，用于治疗复发或难治性滤泡性淋巴瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1989772840.SGD","IE000MB6IJN5.SGD","IYH","LU2133065610.SGD","LU1037948897.HKD","LU1839511570.USD","BK4533","LU0098860793.USD","LU1934455863.HKD","LU1670627923.USD","LU1244550494.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","LU2237443549.SGD","RXL","IE00BGHQF631.EUR","LU1718418525.SGD","LU2237443622.USD","SG9999003800.SGD","PPH","IE00B19Z3B42.SGD","LU0689626769.HKD","LU1291159041.SGD","LU0057025933.USD","FTXH","IE00B2B36J28.USD","BK4585","LU2089283258.USD","SG9999015952.SGD","LU0661504455.SGD","LU0949170772.SGD","IE00B42XCP33.USD","LU0234570918.USD","IE00BDGV0183.EUR","IE000WAW04H5.SGD","LU1585245621.USD","LU0553294199.USD","LU1023059063.AUD","LU1061106388.HKD","LU0738911758.USD","LU0128525929.USD","IE000SO60NU8.SGD","LU1074936037.SGD","LU0795875086.SGD","AGNG","LU0203345920.USD","LU1934455277.USD","BK4581","LU1093756168.USD","ABBV","LU0965508806.USD","LU0203347892.USD","LU1551013425.SGD","LU0965509283.SGD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","LU1496350171.SGD","LU0310799852.SGD","LU0912757837.SGD","LU0029864427.USD","LU2347655156.SGD","LU1496350502.SGD","LU0820561818.USD","LU2023251221.USD","LU0545039389.USD","LU0985320562.USD","LU2237443978.SGD","IE000F7OJYX1.SGD","LU1267930573.SGD","LU0868494708.USD","LU1003077747.HKD","IE00B3PB1722.GBP","LU0124676726.USD","LU0689472784.USD","LU0861579265.USD","LU0114720955.EUR","LU0211328371.USD","LU1989772923.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","IE0009355771.USD","SG9999015945.SGD","LU2112291526.USD","LU0432979614.USD","LU0417517546.SGD","LU1244550577.SGD","LU2237443895.HKD","LU0868494617.USD","LU0943347566.SGD","SG9999015986.USD","BK4559","LU0170899867.USD","LU1732799900.SGD","IE00B4R5TH58.HKD","LU2087621335.USD","IE00BVYPNW00.USD","LU0256863811.USD","IE0000B7K699.USD","LU0708994859.HKD","LU0942090050.USD","IE0002141913.USD","IE00BBT3K403.USD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0965509010.AUD","LU0058720904.USD","LU1267930490.SGD","LU0820561909.HKD","LU0198837287.USD","LU0795875169.SGD","LU0859254822.USD","LU2237443382.USD","FHLC","LU2468319806.SGD","LU0511384066.AUD","BK4588","LU1093756325.SGD","LU1670628061.USD","LU0289961442.SGD","VHT","LU2357627491.SGD","LU0472753341.HKD","XLV","IE00BVYPNV92.GBP","LU2129689431.USD","LU1989771016.USD","IE0004445239.USD","LU2237443465.HKD","LU0965509101.SGD","JDOC","SG9999001440.SGD","BK4566","LU1244550221.USD","LU1551013342.USD","LU2089284900.SGD","LU0289739343.SGD","LU0289739699.SGD","LU2089984988.USD","LU1430594728.SGD","LU0069063385.USD","BK4534","LU2129689514.USD","PJP","LU2129689605.HKD","IE00B19Z3581.USD","BK4550","LU0256863902.USD","IE000BZT7R73.USD","LU0122379950.USD","SG9999011175.SGD","LU1983299246.USD","LU1934455194.USD","LU0211327993.USD","LU0882574055.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1162221912.USD","IXJ","SG9999015978.USD","LU0158827948.USD","IE0002270589.USD","LU0456855351.SGD","LU1732800096.USD","LU0310800379.SGD","LU1929549753.HKD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181578824","title":"Genmab宣布Epcoritamab联合来那度胺三期试验取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1181578824","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181578824?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:17","pubTimestamp":1783322279,"startTime":"0","endTime":"0","summary":"Genmab A/S公布了一项三期临床试验的积极结果，该试验评估了Epcoritamab联合来那度胺在复发/难治性弥漫性大B细胞淋巴瘤患者中的疗效。数据显示，该联合疗法在无进展生存期方面取得了统计学上的显著改善。\n这项名为EPCORE DLBCL-4的试验达到了其主要终点，结果显示，与对照组相比，该治疗方案可将疾病进展或死亡的风险降低高达60%。此外，Epcoritamab联合来那度胺展现出了一致的安全性特征。\nGenmab及其合作伙伴艾伯维公司计划就EPCORE DLBCL-4的试验结果与监管机构进行沟通。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0122379950.USD","IE00BDGV0183.EUR","LU0820561909.HKD","LU0289739699.SGD","LU1585245621.USD","LU0203345920.USD","LU0661504455.SGD","LU1670628061.USD","LU0256863902.USD","LU0965508806.USD","LU1093756168.USD","IE00B3PB1722.GBP","LU2089284900.SGD","LU2237443622.USD","IE0002270589.USD","LU0820561818.USD","LU1496350502.SGD","LU1718418525.SGD","LU0456855351.SGD","LU0708994859.HKD","BK4581","LU0553294199.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1291159041.SGD","SG9999015945.SGD","LU2237443382.USD","MEDX","LU0198837287.USD","LU0211328371.USD","LU0310800379.SGD","LU1244550494.USD","LU0256863811.USD","IE00BLSP4452.SGD","LU1267930490.SGD","LU1934455277.USD","LU2129689605.HKD","LU2237443978.SGD","LU1003077747.HKD","IE00BGHQF631.EUR","LU2129689514.USD","LU0310799852.SGD","LU1989771016.USD","IE000MB6IJN5.SGD","LU0057025933.USD","BK4585","BK4559","IE00BLSP4239.USD","LU1983299246.USD","IXJ","PPH","IE000BZT7R73.USD","LU1244550221.USD","LU0882574055.USD","IE0000B7K699.USD","LU0170899867.USD","LU1074936037.SGD","LU1267930573.SGD","SG9999003800.SGD","LU0689626769.HKD","FTXH","LU0234572021.USD","BK4533","LU1929549753.HKD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0124676726.USD","LU2129689431.USD","IE00BVYPNV92.GBP","IE000SO60NU8.SGD","RXL","LU1023059063.AUD","FHLC","ABBV","LU0949170772.SGD","LU2133065610.SGD","LU2089283258.USD","IYH","IE000F7OJYX1.SGD","LU1162221912.USD","IE0009355771.USD","LU0432979614.USD","LU0912757837.SGD","LU1732799900.SGD","LU1244550577.SGD","LU1430594728.SGD","LU0211327993.USD","LU1551013425.SGD","LU1670627923.USD","IE00BJJMRZ35.SGD","LU0289739343.SGD","LU0545039389.USD","LU0738911758.USD","LU2089984988.USD","BK4588","BK4534","LU2237443465.HKD","LU0795875169.SGD","IE00BVYPNW00.USD","SG9999015978.USD","BK4550","LU0985320562.USD","LU0289961442.SGD","LU2357627491.SGD","LU0689472784.USD","BK4566","LU0029864427.USD","SG9999015952.SGD","LU1093756325.SGD","LU0098860793.USD","LU1732800096.USD","LU2347655156.SGD","LU1496350171.SGD","LU0965509283.SGD","LU0943347566.SGD","LU0511384066.AUD","LU0861579265.USD","LU2112291526.USD","LU0795875086.SGD","LU1989772923.USD","SG9999015986.USD","LU1839511570.USD","LU2237443895.HKD","LU1934455194.USD","LU2237443549.SGD","LU0823416689.USD","JDOC","LU0942090050.USD","SG9999011175.SGD","PJP","LU0320765646.SGD","IE00B19Z3581.USD","LU0203347892.USD","LU2023251221.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0114720955.EUR","AGNG","XLV","IE00B42XCP33.USD","BK4139","LU1037948897.HKD","LU0472753341.HKD","IE000WAW04H5.SGD","LU0965509101.SGD","LU1061106388.HKD","LU1934455863.HKD","LU0965509010.AUD","LU1551013342.USD","LU2087621335.USD","LU0058720904.USD","LU0868494708.USD","IE00BBT3K403.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU0069063385.USD","IE0002141913.USD","LU0417517546.SGD","LU0128525929.USD","IE0004445239.USD","LU1037948541.HKD","VHT","LU0158827948.USD","SG9999001440.SGD","LU0859254822.USD","IE00B19Z3B42.SGD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163891833","title":"异动解读｜艾伯维公司盘中上涨3.01%，多项产品获批及积极临床数据持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1163891833","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163891833?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:53","pubTimestamp":1783003988,"startTime":"0","endTime":"0","summary":"7月2日，艾伯维公司盘中上涨3.01%，报259.325美元/股，成交额2.19亿美元。消息面上，公司近期利好密集释放。6月30日，艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果；同期Rinvoq获欧盟CHMP积极意见，拟用于治疗重度斑秃及非节段型白癜风。叠加Skyrizi儿科适应症获欧盟批准、Maviret急性丙肝适应症获批等多项监管进展，公司产品管线价值获市场重新定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647017534","title":"美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647017534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647017534?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:07","pubTimestamp":1782814066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1061106388.HKD","LU1093756325.SGD","LU1923622614.USD","IE00BDGV0183.EUR","IE000SO60NU8.SGD","LU1934455863.HKD","LU2129689514.USD","LU0265550359.USD","LU0114720955.EUR","BK4139","LU2112291526.USD","LU2125909247.SGD","LU0256863902.USD","IE00BVYPNV92.GBP","LU1670628061.USD","SG9999015978.USD","LU0320765646.SGD","LU1023059063.AUD","LU0124676726.USD","IE00B2B36J28.USD","SG9999015945.SGD","SGXZ57979304.SGD","LU0170899867.USD","LU0417517546.SGD","LU0943347566.SGD","LU0965508806.USD","BK4550","LU2433249047.HKD","LU1037948897.HKD","LU0432979614.USD","LU2491050154.USD","LU2237443978.SGD","LU0265550946.USD","ABBV","LU0980610538.SGD","LU0289739699.SGD","LU2491050071.SGD","LU0234570918.USD","BK4585","SG9999015358.SGD","SG9999015986.USD","LU1244550494.USD","SG9999014575.USD","LU0130102774.USD","LU2125154935.USD","LU2361044949.HKD","LU1093756168.USD","LU1116320901.HKD","SG9999014559.SGD","IE00B42XCP33.USD","LU1571399168.USD","LU0965509283.SGD","LU1934455194.USD","LU0198837287.USD","LU0820561818.USD","LU1585245621.USD","LU0868494617.USD","IE00BLSP4452.SGD","LU1035773651.USD","IE000MB6IJN5.SGD","LU1069347547.HKD","LU0912757837.SGD","LU0456855351.SGD","LU2023250504.SGD","LU1066051225.USD","LU0708994859.HKD","LU1066051498.USD","IE00B4R5TH58.HKD","LU0795875086.SGD","LU1929549753.HKD","LU0320765489.SGD","LU1983299246.USD","LU1934455277.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU1551013342.USD","LU2324357040.USD","SG9999011175.SGD","LU0738911758.USD","IE00BBT3K403.USD","LU0289739343.SGD","LU0256863811.USD","LU0689626769.HKD","IE0004445239.USD","LU1989772840.SGD","SG9999015341.SGD","SG9999002232.USD","LU0006306889.USD","LU1066053197.SGD","LU0795875169.SGD","LU0985320562.USD","BK4566","IE00B19Z3581.USD","BK4007","IE0002270589.USD","LU2023251221.USD","LU0122379950.USD","SG9999014542.SGD","LU1201861249.SGD","SG9999003800.SGD","LU2237443549.SGD","LU0868494708.USD","LU1496350502.SGD","IE0009355771.USD","LU1917777945.USD","IE00BSNM7G36.USD","LU1699723380.USD","LU0266013472.USD","LU1116320737.USD","LU1551013425.SGD","LU2468319806.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU1718418525.SGD","LU1003077747.HKD","LU0310800379.SGD","BK4588","LU0965509101.SGD","SG9999001440.SGD","LU2237443622.USD","LU0310799852.SGD","LU2491049909.HKD","LU0965509010.AUD","LU1974910355.USD","LU0949170772.SGD","MRK","LU0211327993.USD","LU2125154778.USD","SG9999002224.SGD","LU2237443382.USD","SG9999001176.SGD","LU1267930490.SGD","LU0859254822.USD","SG9999014567.USD","LU1037948541.HKD","LU2357627491.SGD","IE00B19Z3B42.SGD","IE0000B7K699.USD","LU2237443465.HKD","IE000F7OJYX1.SGD","LU2347655156.SGD","LU0203345920.USD","LU0203347892.USD","LU0106261372.USD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","LU0553294199.USD","IE000BZT7R73.USD","LU0882574055.USD","LU1162221912.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4516","LU0820561909.HKD","LU2237443895.HKD","LU1496350171.SGD","LU2461242641.AUD","LU0511384066.AUD","LU2129689431.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1430594728.SGD","LU2106854487.HKD","LU1941712264.USD","BK4581","LU2129689605.HKD","LU0211331839.USD","LU0211328371.USD","LU0029864427.USD","LU1066051811.HKD","LU2087621335.USD","LU2361044865.SGD","SG9999001176.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU1074936037.SGD","LU0289961442.SGD","BK4559","LU2023250843.SGD","LU1989772923.USD","LU0661504455.SGD","LU2133065610.SGD","LU0058720904.USD","BK4533","LU0238689110.USD","LU0648001328.SGD","LU0069063385.USD","LU0158827948.USD","LU0208291251.USD","LU0689472784.USD","LU0861579265.USD","LU1839511570.USD","LU1941712348.USD","LU0128525929.USD","IE00BGHQF631.EUR","LU2361045086.USD","LU0057025933.USD","LU1732800096.USD","LU0477156953.USD","LU0823416689.USD","IE000M9KFDE8.USD","LU0130517989.USD","LU0942090050.USD","LU2089284900.SGD","LU2089984988.USD","LU2125909593.SGD","SG9999015952.SGD","LU1244550577.SGD","IE0002141913.USD","LU0472753341.HKD","LU1291159041.SGD","LU1670627923.USD","LU0545039389.USD","LU1267930573.SGD","LU1057294990.SGD","LU1244550221.USD","IE000WAW04H5.SGD","LU1732799900.SGD","BK4534","IE00BVYPNW00.USD","LU0098860793.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197525623","title":"独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1197525623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197525623?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:03","pubTimestamp":1782813780,"startTime":"0","endTime":"0","summary":"美国国会议员已发出信函，要求相关方面提供过去约十年间进行的数百项临床试验的详细文件，其中特别要求包含与患者数据保护流程相关的信息。此举旨在对制药行业的临床试验操作，尤其是数据安全与隐私保护环节，进行更深入的审查与监督。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU1201861249.SGD","LU0456855351.SGD","LU2361044865.SGD","IE00BVYPNV92.GBP","LU1116320737.USD","LU0211327993.USD","LU0553294199.USD","SG9999015986.USD","LU1061106388.HKD","LU1989772923.USD","LU2129689431.USD","IE00BJT1NW94.SGD","LU0265550359.USD","LU1917777945.USD","LU1941712264.USD","LU2023250843.SGD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU0965509101.SGD","LU1839511570.USD","LU2089984988.USD","IE00BGHQF631.EUR","LU0029864427.USD","LU0130102774.USD","BK4516","LU0965509283.SGD","LU1923622614.USD","LU2125909593.SGD","IE00BVYPNW00.USD","LU1267930573.SGD","LU0320765489.SGD","LU2491050154.USD","LU0661504455.SGD","LU0820561818.USD","LU1974910355.USD","LU1934455194.USD","BK4139","LU0417517546.SGD","SG9999003800.SGD","IE000MB6IJN5.SGD","LU1162221912.USD","LU1551013425.SGD","LU1983299246.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU0320765646.SGD","BK4550","LU0234572021.USD","IE000SO60NU8.SGD","LU2491050071.SGD","BK4533","LU0310799852.SGD","IE00BBT3K403.USD","LU0477156953.USD","LU0211331839.USD","LU1929549753.HKD","IE00B19Z3581.USD","LU0238689110.USD","LU0170899867.USD","LU0980610538.SGD","LU2133065610.SGD","LU1551013342.USD","LU2237443895.HKD","LU2361045086.USD","LU0211328371.USD","LU0823416689.USD","LU1003077747.HKD","LU1074936037.SGD","SG9999002224.SGD","IE00BDGV0183.EUR","LU0203347892.USD","LU0511384066.AUD","LU2125154778.USD","LU0124676726.USD","IE0002141913.USD","LU0310800379.SGD","SG9999013999.USD","LU0861579265.USD","LU0912757837.SGD","LU0738911758.USD","LU2357627491.SGD","LU0648001328.SGD","SG9999015945.SGD","LU0795875086.SGD","LU2087621335.USD","SG9999014542.SGD","LU2106854487.HKD","LU2468319806.SGD","LU0130517989.USD","SG9999001176.SGD","LU1430594728.SGD","SG9999014567.USD","LU1035773651.USD","IE000M9KFDE8.USD","IE0009355771.USD","LU0820561909.HKD","LU1267930490.SGD","LU0868494708.USD","LU1989771016.USD","SG9999011175.SGD","LU0058720904.USD","BK4534","LU1244550494.USD","IE00B42XCP33.USD","LU2023250504.SGD","LU1670628061.USD","LU0266013472.USD","LU0114720955.EUR","IE000WAW04H5.SGD","LU0472753341.HKD","SG9999001440.SGD","BK4007","LU1496350171.SGD","LU0098860793.USD","LU1496350502.SGD","LU1732800096.USD","LU2461242641.AUD","IE0004445239.USD","LU1093756325.SGD","LU1670627923.USD","LU1934455277.USD","LU2237443978.SGD","LU0289739699.SGD","LU1699723380.USD","LU1066053197.SGD","LU0708994859.HKD","LU0795875169.SGD","LU0882574055.USD","LU0942090050.USD","LU0256863902.USD","LU0949170772.SGD","LU0965509010.AUD","SG9999002232.USD","LU1066051225.USD","LU2324357040.USD","LU1989772840.SGD","LU1244550221.USD","LU1057294990.SGD","LU0289961442.SGD","LU1093756168.USD","MRK","IE00B4R5TH58.HKD","LU2237443622.USD","LU1571399168.USD","LU0208291251.USD","LU0057025933.USD","LU1023059063.AUD","BK4581","LU2129689605.HKD","LU0689626769.HKD","LU0689472784.USD","SG9999015358.SGD","LU1585245621.USD","LU0943347566.SGD","BK4559","LU1732799900.SGD","LU0198837287.USD","LU2023251221.USD","LU2112291526.USD","IE000F7OJYX1.SGD","LU0069063385.USD","LU1066051811.HKD","IE00B3PB1722.GBP","BK4588","IE00BFTCPJ56.SGD","LU0006306889.USD","LU1116320901.HKD","LU2360032135.SGD","LU0985320562.USD","SG9999015952.SGD","LU1037948897.HKD","SG9999015341.SGD","LU2125154935.USD","ABBV","LU2237443549.SGD","LU1066051498.USD","LU1934455863.HKD","SG9999014559.SGD","LU2491049909.HKD","LU0965508806.USD","LU0432979614.USD","LU0289739343.SGD","LU2237443382.USD","LU1069347547.HKD","LU1941712348.USD","SG9999001176.USD","LU0070302665.USD","LU2237443465.HKD","LU0859254822.USD","LU1718418525.SGD","SG9999014575.USD","LU2129689514.USD","LU0868494617.USD","IE00BN8TJ469.HKD","LU2433249047.HKD","LU0128525929.USD","SG9999015978.USD","LU2125909247.SGD","IE0000B7K699.USD","LU0545039389.USD","LU0106261372.USD","LU0256863811.USD","BK4566","LU2089283258.USD","IE000BZT7R73.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU0203345920.USD","SGXZ57979304.SGD","LU0265550946.USD","LU0158827948.USD","LU2361044949.HKD","BK4585","LU0234570918.USD","LU1037948541.HKD","IE00BLSP4239.USD","LU2089284900.SGD","LU2347655156.SGD","LU1244550577.SGD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110159985","title":"艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110159985","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110159985?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:53","pubTimestamp":1782766394,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Epcoritamab联合来那度胺，在治疗复发或难治性弥漫性大B细胞淋巴瘤患者的三期临床试验中，取得了积极成果。这一关键性研究的正面数据，为这种侵袭性淋巴瘤患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","BK4588","LU1093756325.SGD","IE000MB6IJN5.SGD","IE00B19Z3581.USD","BK4550","IE00B42XCP33.USD","LU0511384066.AUD","BK4585","IE00BN8TJ469.HKD","LU0820561909.HKD","LU1934455277.USD","LU1989771016.USD","LU0708994859.HKD","BK4559","LU2237443549.SGD","SG9999011175.SGD","LU0661504455.SGD","LU1670628061.USD","LU0553294199.USD","LU1934455194.USD","SG9999015945.SGD","LU1430594728.SGD","BK4534","LU0432979614.USD","LU2129689431.USD","IE00BDGV0183.EUR","LU2237443465.HKD","IE000BZT7R73.USD","LU0211327993.USD","IE00B3PB1722.GBP","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0211328371.USD","ABBV","IE00BVYPNW00.USD","LU0820561818.USD","LU1023059063.AUD","LU1093756168.USD","LU0545039389.USD","LU1496350502.SGD","LU2237443622.USD","LU0985320562.USD","IE0004445239.USD","LU1732800096.USD","LU2089283258.USD","LU1839511570.USD","LU1244550494.USD","IE00BVYPNV92.GBP","IE0002141913.USD","LU0289739699.SGD","SG9999015952.SGD","IE0009355771.USD","LU0795875086.SGD","LU1989772923.USD","LU0472753341.HKD","LU1551013342.USD","IE000WAW04H5.SGD","LU0058720904.USD","LU0289739343.SGD","LU0823416689.USD","LU1496350171.SGD","LU0310800379.SGD","LU0689472784.USD","BK4139","LU1061106388.HKD","LU0114720955.EUR","LU2129689514.USD","LU0320765646.SGD","LU1244550221.USD","LU0203347892.USD","LU1074936037.SGD","LU2237443978.SGD","IE00BGHQF631.EUR","BK4533","LU0256863811.USD","BK4581","LU2089284900.SGD","LU0029864427.USD","LU0310799852.SGD","LU0965508806.USD","LU1291159041.SGD","LU2133065610.SGD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0965509101.SGD","LU1037948897.HKD","IE000SO60NU8.SGD","LU1551013425.SGD","SG9999015986.USD","LU0868494617.USD","LU0170899867.USD","LU1983299246.USD","IE00BLSP4239.USD","LU0912757837.SGD","LU0098860793.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU2237443382.USD","LU0417517546.SGD","LU1670627923.USD","LU2237443895.HKD","LU1244550577.SGD","LU0859254822.USD","LU2357627491.SGD","LU2468319806.SGD","LU1057294990.SGD","LU0256863902.USD","LU0069063385.USD","LU1037948541.HKD","IE0000B7K699.USD","LU0158827948.USD","LU0234572021.USD","LU0861579265.USD","LU1732799900.SGD","LU2129689605.HKD","LU2347655156.SGD","LU1267930490.SGD","IE00BBT3K403.USD","LU0289961442.SGD","IE000F7OJYX1.SGD","LU2023251221.USD","LU0124676726.USD","LU0943347566.SGD","LU2112291526.USD","LU2089984988.USD","LU0965509283.SGD","LU2087621335.USD","SG9999015978.USD","LU0868494708.USD","LU0057025933.USD","LU1585245621.USD","LU1989772840.SGD","LU0795875169.SGD","IE0002270589.USD","SG9999001440.SGD","LU1718418525.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0456855351.SGD","SG9999003800.SGD","LU0942090050.USD","LU0203345920.USD","LU0965509010.AUD","LU0689626769.HKD","LU1934455863.HKD","LU0234570918.USD","LU1162221912.USD","LU0198837287.USD","LU0949170772.SGD","LU0738911758.USD","LU1267930573.SGD","BK4566","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130790553","title":"艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风","url":"https://stock-news.laohu8.com/highlight/detail?id=1130790553","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130790553?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:08","pubTimestamp":1782716916,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Upadacitinib（商品名：Rinvoq®）已获得欧洲药品管理局人用药品委员会（CHMP）的积极评价，该药物拟用于治疗成人和青少年非节段型白癜风患者。这一积极意见标志着该疗法在欧盟监管审批进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","IE000WAW04H5.SGD","LU0882574055.USD","LU2357627491.SGD","LU0965509010.AUD","IE000MB6IJN5.SGD","LU1037948541.HKD","SG9999015986.USD","IE0000B7K699.USD","SG9999015945.SGD","LU0661504455.SGD","LU1023059063.AUD","LU1989772923.USD","LU0965508806.USD","LU2237443622.USD","LU0456855351.SGD","IE00BGHQF631.EUR","LU0289739699.SGD","LU1093756168.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0545039389.USD","LU2237443978.SGD","LU2023251221.USD","LU1430594728.SGD","IE00B42XCP33.USD","LU0942090050.USD","LU2237443465.HKD","LU0211327993.USD","LU0203345920.USD","LU0310799852.SGD","IE0004445239.USD","LU0553294199.USD","LU0198837287.USD","LU0170899867.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU2133065610.SGD","LU2129689431.USD","LU1267930573.SGD","LU1267930490.SGD","LU0943347566.SGD","LU0823416689.USD","LU0320765646.SGD","LU0689626769.HKD","LU2347655156.SGD","LU0708994859.HKD","LU0795875169.SGD","LU1718418525.SGD","IE00BLSP4452.SGD","LU1670628061.USD","LU0211328371.USD","LU0256863811.USD","LU0965509283.SGD","LU0820561909.HKD","LU1093756325.SGD","IE000BZT7R73.USD","LU0795875086.SGD","IE00BN8TJ469.HKD","LU0310800379.SGD","IE00BDGV0183.EUR","BK4533","LU0122379950.USD","LU0058720904.USD","LU2129689605.HKD","LU1244550494.USD","LU1983299246.USD","LU1037948897.HKD","LU1929549753.HKD","IE000F7OJYX1.SGD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1732800096.USD","LU0820561818.USD","BK4588","SG9999003800.SGD","BK4550","IE00BJJMRZ35.SGD","LU0859254822.USD","LU1989771016.USD","LU1551013425.SGD","LU1934455194.USD","LU2089283258.USD","LU0069063385.USD","LU2237443382.USD","BK4566","IE00BBT3K403.USD","LU1003077747.HKD","LU0057025933.USD","LU1496350171.SGD","LU0965509101.SGD","LU0203347892.USD","LU1989772840.SGD","LU0124676726.USD","IE00BJT1NW94.SGD","LU1244550221.USD","LU2089984988.USD","LU0511384066.AUD","SG9999015978.USD","SG9999011175.SGD","LU0234572021.USD","LU0985320562.USD","LU0868494617.USD","LU2468319806.SGD","IE0002141913.USD","IE0009355771.USD","LU0738911758.USD","LU0472753341.HKD","LU0029864427.USD","LU0256863902.USD","LU1934455863.HKD","LU1496350502.SGD","LU2089284900.SGD","LU1162221912.USD","IE00BVYPNV92.GBP","LU1057294990.SGD","ABBV","LU0234570918.USD","IE00BVYPNW00.USD","LU1670627923.USD","IE0002270589.USD","LU0128525929.USD","BK4585","LU0289961442.SGD","LU1934455277.USD","IE00B4R5TH58.HKD","IE00B3PB1722.GBP","IE00B2B36J28.USD","LU0912757837.SGD","LU1585245621.USD","LU0689472784.USD","LU2237443549.SGD","LU0868494708.USD","LU2129689514.USD","LU1244550577.SGD","BK4581","IE000SO60NU8.SGD","LU2112291526.USD","LU0098860793.USD","SG9999001440.SGD","BK4559","LU0432979614.USD","BK4534","LU1074936037.SGD","LU2237443895.HKD","LU1551013342.USD","LU0417517546.SGD","LU2087621335.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU1839511570.USD","LU0289739343.SGD","LU0949170772.SGD","LU0158827948.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143206979","title":"一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143206979","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143206979?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:18","pubTimestamp":1782699520,"startTime":"0","endTime":"0","summary":"默克提出每股73美元的收购要约后，Bio-Techne股价本周上涨22.5%，较该公司周三收盘价溢价24%。艾伯维斥资109亿美元收购Apogee，强化免疫学领域战略艾伯维股价本周上涨17%。联合大陆航空股价上涨，油价下跌和分析师看涨情绪提振航空股本周，联合大陆航空股价上涨15%。为了进一步提升股东价值，康宁董事会宣布派发每股0.28美元的季度股息。股息将于9月29日支付给截至8月31日登记在册的股东。","market":"us","thumbnail":"https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","GLW","INCY","IQV","RVTY","UAL","GLWG","TECH","CRL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1187753194","title":"异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187753194","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187753194?lang=zh_cn&edition=full","pubTime":"2026-06-27 03:56","pubTimestamp":1782503815,"startTime":"0","endTime":"0","summary":"6月26日，艾伯维公司盘中上涨3.31%，报251.23美元/股，成交额22.61亿美元。消息面上，公司近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取核心资产zumilokibart，UBS认为该交易估值\"充分合理\"，该药在特应性皮炎及哮喘领域具备\"超级重磅炸弹潜力\"。同时，Canaccord Genuity将目标价上调至273美元，Rothschild & Co Redburn上调至284美元，均维持买入评级。产品端，Skyrizi获欧盟批准扩展至儿童银屑病，Maviret获批用于急性丙肝，多重利好共振持续推升股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199295327","title":"异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199295327","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199295327?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:49","pubTimestamp":1782398942,"startTime":"0","endTime":"0","summary":"6月25日，艾伯维公司盘中上涨3.23%，报242.47美元/股，成交额3.75亿美元。消息面上，艾伯维近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取其核心资产zumilokibart，强化免疫学管线布局。Canaccord Genuity随后将艾伯维目标价从265美元上调至273美元，维持买入评级。此外，艾伯维旗下Skyrizi获欧盟批准用于儿童银屑病、Maviret获批用于急性丙肝治疗，旗下艾尔建美学新品Boey在加拿大获批，多重产品线利好共同提振市场信心。交易预计三季度完成，反垄断风险有限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136601431","title":"医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹","url":"https://stock-news.laohu8.com/highlight/detail?id=1136601431","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136601431?lang=zh_cn&edition=full","pubTime":"2026-06-25 21:06","pubTimestamp":1782392808,"startTime":"0","endTime":"0","summary":"医美行业巨头们已证实，由GLP-1减肥药引发的面部脂肪流失现象——“司美格鲁肽脸”——是真实存在的副作用。这一市场新动态，正为专注于再生医学的医美公司开辟出全新的竞争赛道。一家新近上市的再生医学领域参与者，已明确表示将瞄准这一快速增长的需求。市场分析指出，“司美格鲁肽脸”现象催生的不仅是新的治疗需求，更是一个潜在的交叉增长市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","IE00BDGV0183.EUR","LU0823416689.USD","LU0320765646.SGD","IE00BLSP4239.USD","LU0310800379.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE000F7OJYX1.SGD","LU1244550221.USD","LU0689472784.USD","LU0859254822.USD","IE00B4R5TH58.HKD","LU2087621335.USD","LU2357627491.SGD","SG9999001440.SGD","LU0029864427.USD","LU0122379950.USD","IE000MB6IJN5.SGD","LU0661504455.SGD","LU1057294990.SGD","LU0256863811.USD","LU0234572021.USD","LU1934455277.USD","LU1244550494.USD","LU1732799900.SGD","LU1496350171.SGD","LU2237443465.HKD","LU0211328371.USD","LU0114720955.EUR","LU2237443622.USD","LU1989772840.SGD","LU0310799852.SGD","IE000SO60NU8.SGD","LU1291159041.SGD","LU0289961442.SGD","LU0882574055.USD","INMD","LU1037948541.HKD","LU1839511570.USD","LU0203347892.USD","LU0069063385.USD","LU1670628061.USD","LU1983299246.USD","LU2023251221.USD","LU0170899867.USD","LU1732800096.USD","IE000BZT7R73.USD","LU0211327993.USD","LU0965509283.SGD","LU0868494708.USD","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU0689626769.HKD","IE000WAW04H5.SGD","CNXU","LU1430594728.SGD","LU1670627923.USD","LU0820561909.HKD","LU0511384066.AUD","LU0472753341.HKD","SG9999015978.USD","LU0965508806.USD","LU0545039389.USD","LU0912757837.SGD","IE00B2B36J28.USD","LU1551013342.USD","BK4588","LU2347655156.SGD","SG9999015945.SGD","LU0098860793.USD","IE00BLSP4452.SGD","LU0289739343.SGD","LU1989771016.USD","LU1718418525.SGD","LU1061106388.HKD","IE00BGHQF631.EUR","LU0965509010.AUD","BK4139","IE00B19Z3B42.SGD","LU2468319806.SGD","SG9999015986.USD","ABBV","LU1244550577.SGD","LU2237443382.USD","LU0417517546.SGD","LU2237443978.SGD","LU1267930573.SGD","SG9999011175.SGD","BK4585","IE0004445239.USD","LU1093756325.SGD","LU2237443549.SGD","LU0795875169.SGD","BK4566","IE00BVYPNW00.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","LU0942090050.USD","IE00BBT3K403.USD","LU0965509101.SGD","LU1934455194.USD","LU0158827948.USD","LU2089984988.USD","SG9999015952.SGD","LU0795875086.SGD","LU2133065610.SGD","LU1003077747.HKD","LU1551013425.SGD","LU0949170772.SGD","ESTA","LU2089283258.USD","IE0002141913.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU1093756168.USD","IE00B42XCP33.USD","BK4082","LU0820561818.USD","LU1267930490.SGD","LU0203345920.USD","LU1023059063.AUD","LU0057025933.USD","LU0738911758.USD","LU0198837287.USD","IE00B19Z3581.USD","BK4581","LU0256863902.USD","LU2324357040.USD","LU2089284900.SGD","BK4198","BK4533","LU2129689431.USD","LU2129689514.USD","LU0456855351.SGD","LU0124676726.USD","LU1162221912.USD","BK4559","LU2129689605.HKD","LU0868494617.USD","LU0861579265.USD","LU1989772923.USD","IE0002270589.USD","LU0943347566.SGD","LU1929549753.HKD","SG9999003800.SGD","BK4534","IE00BN8TJ469.HKD","LU1074936037.SGD","LU2112291526.USD","IE0000B7K699.USD","LU0985320562.USD","LU0708994859.HKD","LU0128525929.USD","IE00B3PB1722.GBP","BK4550","LU0432979614.USD","LU1934455863.HKD","LU0234570918.USD","LU2237443895.HKD","LU1585245621.USD","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117059267","title":"艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1117059267","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117059267?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:02","pubTimestamp":1782216166,"startTime":"0","endTime":"0","summary":"艾伯维公司旗下的爱力根美学部门即将启动相关培训工作，并为新产品Boey在未来几个月内的商业上市进行筹备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0000B7K699.USD","IE0002270589.USD","LU0029864427.USD","LU1496350171.SGD","LU2237443622.USD","LU0689472784.USD","BK4533","IE00B19Z3581.USD","LU1244550221.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU2089984988.USD","LU0158827948.USD","SG9999003800.SGD","LU2129689431.USD","LU1983299246.USD","LU1061106388.HKD","LU1929549753.HKD","LU0170899867.USD","SG9999015978.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU0965509283.SGD","LU0511384066.AUD","LU0708994859.HKD","LU1074936037.SGD","IE00BSNM7G36.USD","LU1732799900.SGD","LU1670627923.USD","LU1934455194.USD","LU0417517546.SGD","LU2237443382.USD","ABBV","LU2237443895.HKD","LU0128525929.USD","LU0203345920.USD","LU0256863902.USD","IE000MB6IJN5.SGD","LU0432979614.USD","LU0965509010.AUD","LU2089283258.USD","LU0211327993.USD","LU0689626769.HKD","LU1718418525.SGD","LU0859254822.USD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU2237443549.SGD","IE00B2B36J28.USD","LU0795875086.SGD","LU0203347892.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","IE000SO60NU8.SGD","LU1037948541.HKD","LU0472753341.HKD","LU1267930573.SGD","LU0211328371.USD","SG9999011175.SGD","LU0289739699.SGD","LU0545039389.USD","LU1267930490.SGD","LU0234570918.USD","LU2129689605.HKD","SG9999015952.SGD","IE0004445239.USD","IE00BDGV0183.EUR","LU1244550494.USD","IE0009355771.USD","SG9999015986.USD","LU1989772923.USD","SG9999001440.SGD","LU1670628061.USD","LU2089284900.SGD","IE000F7OJYX1.SGD","IE0002141913.USD","LU1037948897.HKD","LU1551013425.SGD","BK4585","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1244550577.SGD","IE00B3PB1722.GBP","LU0310799852.SGD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU0985320562.USD","LU2357627491.SGD","IE00BVYPNV92.GBP","IE00B42XCP33.USD","LU0882574055.USD","LU1732800096.USD","LU0942090050.USD","BK4588","SG9999015945.SGD","LU1093756325.SGD","LU2023251221.USD","LU0456855351.SGD","LU1551013342.USD","LU1430594728.SGD","LU1291159041.SGD","LU2237443978.SGD","IE000BZT7R73.USD","LU2237443465.HKD","LU0738911758.USD","LU0058720904.USD","LU0949170772.SGD","LU0943347566.SGD","LU1839511570.USD","LU0868494617.USD","LU1585245621.USD","LU1934455863.HKD","LU2347655156.SGD","LU0661504455.SGD","BK4534","LU0912757837.SGD","LU1162221912.USD","LU0820561818.USD","LU0965508806.USD","BK4559","IE00BN8TJ469.HKD","LU1989772840.SGD","LU1057294990.SGD","LU1934455277.USD","LU2087621335.USD","LU0057025933.USD","LU0820561909.HKD","LU0198837287.USD","LU2129689514.USD","IE00BVYPNW00.USD","LU0234572021.USD","LU0320765646.SGD","BK4139","LU0289961442.SGD","LU0553294199.USD","LU0310800379.SGD","LU0868494708.USD","LU1093756168.USD","IE000WAW04H5.SGD","LU1003077747.HKD","IE00BBT3K403.USD","LU0256863811.USD","IE00BGHQF631.EUR","BK4550","BK4581","LU2112291526.USD","LU0122379950.USD","LU0069063385.USD","LU0098860793.USD","BK4566","LU0965509101.SGD","LU0124676726.USD","LU0289739343.SGD","LU0114720955.EUR","LU1023059063.AUD","LU0823416689.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143485673","title":"艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1143485673","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143485673?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:00","pubTimestamp":1782205239,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Maviret®（格卡瑞韦/哌仑他韦）已获得欧洲委员会的批准，用于治疗急性丙型肝炎病毒感染患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","IE0002141913.USD","LU0289961442.SGD","LU0511384066.AUD","LU0942090050.USD","LU1839511570.USD","LU0859254822.USD","LU2129689605.HKD","LU0820561909.HKD","LU2089984988.USD","SG9999001440.SGD","LU0689626769.HKD","LU1551013425.SGD","LU0128525929.USD","LU1267930573.SGD","LU0708994859.HKD","LU0553294199.USD","LU1551013342.USD","LU2129689514.USD","LU2357627491.SGD","LU1061106388.HKD","LU1291159041.SGD","LU0943347566.SGD","IE00BLSP4452.SGD","LU1496350502.SGD","LU0289739343.SGD","LU0949170772.SGD","LU1496350171.SGD","IE00B3PB1722.GBP","LU0256863811.USD","LU1162221912.USD","LU1983299246.USD","IE000MB6IJN5.SGD","LU2023251221.USD","IE0002270589.USD","LU2237443382.USD","SG9999015952.SGD","BK4559","LU1244550221.USD","SG9999015978.USD","LU2129689431.USD","LU1057294990.SGD","LU2237443622.USD","LU0882574055.USD","LU0158827948.USD","BK4139","LU0289739699.SGD","LU0868494708.USD","LU1037948541.HKD","IE00B19Z3581.USD","LU0472753341.HKD","LU2089284900.SGD","LU1934455194.USD","LU2347655156.SGD","BK4585","IE00BVYPNV92.GBP","LU0198837287.USD","LU0689472784.USD","LU1244550577.SGD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU1934455863.HKD","IE0004445239.USD","IE000WAW04H5.SGD","IE00BJJMRZ35.SGD","BK4588","SG9999015986.USD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0029864427.USD","LU0058720904.USD","LU1732799900.SGD","LU1989772840.SGD","LU2089283258.USD","LU2468319806.SGD","SG9999003800.SGD","LU0203345920.USD","LU0234570918.USD","LU1267930490.SGD","LU2087621335.USD","LU0069063385.USD","LU0965509101.SGD","IE00BVYPNW00.USD","LU0823416689.USD","IE00B2B36J28.USD","LU0820561818.USD","LU0965508806.USD","LU1003077747.HKD","LU2133065610.SGD","LU1430594728.SGD","LU0985320562.USD","LU1732800096.USD","LU0114720955.EUR","IE00B42XCP33.USD","LU1093756168.USD","LU0320765646.SGD","BK4581","LU0456855351.SGD","LU1670627923.USD","LU0965509010.AUD","IE000SO60NU8.SGD","LU0545039389.USD","LU0310799852.SGD","IE000F7OJYX1.SGD","LU1074936037.SGD","IE0000B7K699.USD","LU1037948897.HKD","LU1023059063.AUD","LU1989771016.USD","LU0170899867.USD","SG9999011175.SGD","LU1929549753.HKD","BK4534","ABBV","IE00BFTCPJ56.SGD","LU1585245621.USD","IE0009355771.USD","LU0432979614.USD","LU0203347892.USD","LU2237443549.SGD","LU2237443978.SGD","BK4533","IE00BJT1NW94.SGD","SG9999015945.SGD","LU0310800379.SGD","LU0795875086.SGD","LU1934455277.USD","LU0417517546.SGD","LU0124676726.USD","LU0738911758.USD","LU0211328371.USD","LU1244550494.USD","LU0868494617.USD","LU0795875169.SGD","IE00BSNM7G36.USD","LU0912757837.SGD","LU0965509283.SGD","IE00BN8TJ469.HKD","LU1670628061.USD","LU2112291526.USD","LU2237443895.HKD","BK4550","BK4566","LU0211327993.USD","LU0122379950.USD","LU1989772923.USD","LU0861579265.USD","LU0057025933.USD","LU2237443465.HKD","IE00BGHQF631.EUR","LU0098860793.USD","LU0256863902.USD","LU1093756325.SGD","LU1718418525.SGD","IE00B4R5TH58.HKD","LU0661504455.SGD","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645888902","title":"艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888902","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645888902?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:28","pubTimestamp":1782203332,"startTime":"0","endTime":"0","summary":"该药现可用于治疗6岁及以上、适合接受系统治疗的中重度斑块状银屑病儿童和青少年患者。临床数据显示，在入组的137名儿童及青少年患者中，SKYRIZI展现出的安全性特征与此前在成年患者中观察到的高度一致，未发现任何新的安全信号。艾伯维高级副总裁兼首席科学官Roopal Thakkar博士表示，儿童斑块状银屑病具有极高的临床复杂性。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","LU0942090050.USD","LU0203345920.USD","LU1057294990.SGD","ABBV","BK4550","LU0234570918.USD","LU1989771016.USD","LU1291159041.SGD","LU2089283258.USD","LU2133065610.SGD","IE00BLSP4239.USD","LU0882574055.USD","LU1934455277.USD","LU2237443382.USD","FSXEmain","LU0057025933.USD","LU1496350171.SGD","SG9999015945.SGD","FESXmain","IE00B2B36J28.USD","LU0320765646.SGD","LU0912757837.SGD","LU1023059063.AUD","LU2237443549.SGD","LU1244550221.USD","IE00BLSP4452.SGD","LU0511384066.AUD","LU0965508806.USD","IE00BGHQF631.EUR","SG9999011175.SGD","LU2112291526.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","BK4534","LU0868494617.USD","IE000BZT7R73.USD","LU0795875086.SGD","LU2468319806.SGD","IE0009355771.USD","LU0738911758.USD","LU0417517546.SGD","LU0472753341.HKD","BK4533","LU0949170772.SGD","LU2089284900.SGD","LU1162221912.USD","LU1244550494.USD","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130332746","title":"艾伯维公司宣布欧盟委员会批准Skyrizi®（瑞莎珠单抗）用于治疗中重度斑块状银屑病儿科患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1130332746","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130332746?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:00","pubTimestamp":1782198018,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Skyrizi®（通用名：瑞莎珠单抗）已获得欧盟委员会的批准，用于治疗中重度斑块状银屑病的儿科患者。这一监管批准为患有该慢性皮肤疾病的儿童和青少年提供了一个新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","IE00B2B36J28.USD","LU2089984988.USD","LU0098860793.USD","IE00BVYPNV92.GBP","LU1162221912.USD","IE00BJT1NW94.SGD","LU1267930490.SGD","LU0545039389.USD","LU0861579265.USD","LU0069063385.USD","LU0689626769.HKD","LU1839511570.USD","LU1003077747.HKD","IE000SO60NU8.SGD","BK4566","LU1551013425.SGD","LU1670628061.USD","LU2237443382.USD","BK4559","LU0965509283.SGD","IE0000B7K699.USD","IE00BVYPNW00.USD","LU1037948897.HKD","LU2347655156.SGD","LU0289961442.SGD","LU0882574055.USD","LU0289739343.SGD","LU2087621335.USD","LU0203345920.USD","LU0689472784.USD","LU1430594728.SGD","LU2129689514.USD","LU0128525929.USD","LU0868494708.USD","LU1244550221.USD","IE00BGHQF631.EUR","LU0124676726.USD","IE00BN8TJ469.HKD","LU0256863902.USD","LU0795875086.SGD","LU0058720904.USD","LU1037948541.HKD","IE0002141913.USD","LU0511384066.AUD","LU0868494617.USD","LU2112291526.USD","LU0553294199.USD","LU1074936037.SGD","LU0965509010.AUD","LU1732800096.USD","LU0310800379.SGD","IE00B4R5TH58.HKD","LU1989772840.SGD","LU1934455863.HKD","LU2237443622.USD","SG9999015978.USD","LU1244550494.USD","BK4581","LU0738911758.USD","LU0057025933.USD","LU2089284900.SGD","LU0114720955.EUR","LU1496350171.SGD","IE00BBT3K403.USD","BK4550","IE00BLSP4452.SGD","SG9999015952.SGD","IE00B19Z3581.USD","LU0912757837.SGD","SG9999015945.SGD","LU0029864427.USD","LU2237443895.HKD","IE0004445239.USD","LU2129689605.HKD","LU0234572021.USD","LU0289739699.SGD","LU0158827948.USD","LU0432979614.USD","LU2129689431.USD","SG9999015986.USD","LU0823416689.USD","LU0211327993.USD","IE00BSNM7G36.USD","LU1023059063.AUD","ABBV","LU1267930573.SGD","LU0122379950.USD","LU0985320562.USD","LU0820561909.HKD","LU1093756325.SGD","LU1732799900.SGD","LU2468319806.SGD","LU1983299246.USD","LU0203347892.USD","LU0211328371.USD","IE00B3PB1722.GBP","SG9999011175.SGD","LU1929549753.HKD","IE0002270589.USD","IE000WAW04H5.SGD","LU0198837287.USD","LU1670627923.USD","LU1585245621.USD","LU0795875169.SGD","LU1551013342.USD","LU0943347566.SGD","LU1989771016.USD","LU0942090050.USD","LU0310799852.SGD","LU0949170772.SGD","LU1291159041.SGD","IE00BLSP4239.USD","IE00B42XCP33.USD","IE000MB6IJN5.SGD","LU1244550577.SGD","LU2237443465.HKD","LU2237443978.SGD","BK4139","LU1934455277.USD","LU0234570918.USD","IE000BZT7R73.USD","BK4588","LU2023251221.USD","BK4585","LU0708994859.HKD","LU1093756168.USD","SG9999003800.SGD","LU0965508806.USD","LU0456855351.SGD","LU2237443549.SGD","LU0661504455.SGD","BK4533","LU0256863811.USD","LU1718418525.SGD","IE0009355771.USD","IE000F7OJYX1.SGD","LU0859254822.USD","LU0417517546.SGD","LU0820561818.USD","LU1934455194.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2089283258.USD","LU0472753341.HKD","LU1989772923.USD","LU1061106388.HKD","LU1057294990.SGD","SG9999001440.SGD","IE00B19Z3B42.SGD","LU0320765646.SGD","BK4534","LU0965509101.SGD","IE00BDGV0183.EUR","LU2357627491.SGD","LU1496350502.SGD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146210826","title":"AbbVie以109亿美元收购Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1146210826","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146210826?lang=zh_cn&edition=full","pubTime":"2026-06-23 08:57","pubTimestamp":1782176244,"startTime":"0","endTime":"0","summary":"AbbVie同意以约10.9 billion美元全现金收购Apogee Therapeutics，以加强其免疫学产品组合，并加快其在呼吸领域的临床布局。双方于周一联合声明表示，AbbVie将以每股135.11美元现金收购Apogee。Apogee股价于周一交易时段飙升约47%，AbbVie则升3.7%。是次交易将使AbbVie取得Apogee处于临床阶段、用于治疗炎症及免疫疾病的研发产品组合。AbbVie行政总裁Robert Michael于声明中表示，收购Apogee进一步巩固公司现有领导地位，并强化向患者提供创新药物的能力，同时为股东创造长期价值。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AbbVie以109亿美元收购Apogee Therapeutics","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645078578","title":"109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent","url":"https://stock-news.laohu8.com/highlight/detail?id=2645078578","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645078578?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:05","pubTimestamp":1782137159,"startTime":"0","endTime":"0","summary":"根据协议条款，艾伯维将以每股135.11美元的现金价格收购Apogee所有已发行普通股，总股权价值约为109亿美元。艾伯维预计，2026年Skyrizi销售额约为216亿美元，Rinvoq约为102亿美元，两款药物合计将贡献超过310亿美元的年收入，目前已合计占艾伯维季度总营收的约44%。艾伯维方面则表示，Apogee的管线资产具有“重磅炸弹级别的集体峰值销售潜力”。艾伯维计划通过债务融资来完成此次收购。艾伯维以109亿美元收购Apogee，本质上是一场关于时间差的博弈。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457208.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE000F7OJYX1.SGD","IE00BVYPNV92.GBP","LU0942090050.USD","LU0203345920.USD","LU0310799852.SGD","LU1057294990.SGD","LU0820561818.USD","ABBV","BK4550","LU0198837287.USD","LU2089283258.USD","LU0069063385.USD","LU0170899867.USD","LU1061106388.HKD","LU0882574055.USD","LU1934455277.USD","BK4566","LU0965509010.AUD","LU2357627491.SGD","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","APGE","LU1003077747.HKD","LU0943347566.SGD","LU0965509101.SGD","LU0203347892.USD","LU0320765646.SGD","LU0823416689.USD","LU0912757837.SGD","LU1989772923.USD","LU0511384066.AUD","SG9999011175.SGD","LU0820561909.HKD","LU0098860793.USD","LU0985320562.USD","BK4559","LU0545039389.USD","LU0795875086.SGD","LU2468319806.SGD","IE0002141913.USD","IE0009355771.USD","LU0472753341.HKD","LU2087621335.USD","LU0029864427.USD","LU1430594728.SGD","BK4533","LU0058720904.USD","LU1244550494.USD","LU1983299246.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":0.1704},{"period":"3month","weight":0.2353},{"period":"6month","weight":0.1722},{"period":"1year","weight":0.3388},{"period":"ytd","weight":0.1089}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.571429,"avgChangeRate":0.011933},{"month":8,"riseRate":0.538462,"avgChangeRate":0.007409},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}